122 related articles for article (PubMed ID: 8244326)
1. Small lymphocytic non-Hodgkin's lymphoma of suppressor/cytotoxic T-cell phenotype [CD4(-), CD8(+)].
Dorfman DM; Longtine JA; Weinberg DS; Pinkus GS
Hum Pathol; 1993 Nov; 24(11):1253-6. PubMed ID: 8244326
[TBL] [Abstract][Full Text] [Related]
2. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.
Martinez A; Pittaluga S; Villamor N; Colomer D; Rozman M; Raffeld M; Montserrat E; Campo E; Jaffe ES
Am J Surg Pathol; 2004 Jul; 28(7):849-58. PubMed ID: 15223953
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic lymphocytes in B-cell chronic lymphocytic leukemia. A flow cytometric study of peripheral blood, lymph nodes and bone marrow.
Terstappen LW; de Grooth BG; Segers-Nolten I; Greve J
Blut; 1990 Feb; 60(2):81-7. PubMed ID: 1689193
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Boyer DF; Lindeman NI; Harris NL; Ferry JA
Am J Surg Pathol; 2014 Feb; 38(2):279-88. PubMed ID: 24418862
[TBL] [Abstract][Full Text] [Related]
5. Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity.
Weiss C; Wulf G; Ho AD; Hunstein W
Immunol Lett; 1991 Sep; 30(1):113-8. PubMed ID: 1683649
[TBL] [Abstract][Full Text] [Related]
6. Different conditions for generation of non-cytotoxic autorestricted CD4-CD8+ human suppressor T cells and allospecific cytotoxic T lymphocytes in one-way mixed lymphocyte cultures: the role of adherent mononuclear cells.
Balashov KE; Brondz BD
Scand J Immunol; 1991 Nov; 34(5):667-71. PubMed ID: 1835128
[TBL] [Abstract][Full Text] [Related]
7. T-cell chronic lymphocytic leukemia with morphologic and immunologic characteristics of cytotoxic/suppressor phenotype.
Phyliky RL; Li CY; Yam LT
Mayo Clin Proc; 1983 Nov; 58(11):709-20. PubMed ID: 6226834
[TBL] [Abstract][Full Text] [Related]
8. Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype.
Dianzani U; Omedè P; Marmont F; DiFranco D; Fusaro A; Bragardo M; Redoglia V; Giaretta F; Mairone L; Boccadoro M
Blood; 1994 Apr; 83(8):2198-205. PubMed ID: 7909242
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia.
Apostolopoulos A; Symeonidis A; Zoumbos N
Eur J Haematol; 1990 Jan; 44(1):39-44. PubMed ID: 2137786
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion.
Lois N; Hiscott PS; Nash J; Wong D
Arch Ophthalmol; 2000 Dec; 118(12):1692-4. PubMed ID: 11115267
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
Kaleem Z; White G; Zutter MM
Am J Clin Pathol; 2001 Mar; 115(3):396-403. PubMed ID: 11242796
[TBL] [Abstract][Full Text] [Related]
12. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
13. CD8-positive B-cell chronic lymphocytic leukemia. A report of two cases.
Koelliker DD; Steele PE; Hurtubise PE; Flessa HC; Sheng YP; Swerdlow SH
Am J Clin Pathol; 1994 Aug; 102(2):212-6. PubMed ID: 8042591
[TBL] [Abstract][Full Text] [Related]
14. The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.
Deem RL; Targan SR; Niederlehner A; Shanahan F
Clin Exp Immunol; 1990 Jun; 80(3):387-94. PubMed ID: 1695560
[TBL] [Abstract][Full Text] [Related]
15. T-cell form of chronic lymphocytic leukaemia: a reaffirmation of its existence.
Wong KF; Chan JK; Sin VC
Br J Haematol; 1996 Apr; 93(1):157-9. PubMed ID: 8611452
[TBL] [Abstract][Full Text] [Related]
16. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
17. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
18. New aggressive variant of suppressor/cytotoxic T-CLL.
Hui PK; Feller AC; Pileri S; Gobbi M; Lennert K
Am J Clin Pathol; 1987 Jan; 87(1):55-9. PubMed ID: 2948383
[TBL] [Abstract][Full Text] [Related]
19. Morphological characteristics of malignant T-cell lymphomas in baboons.
Yakovleva LA; Lennert K; Chikobava MG; Indzhiia LV; Klotz IN; Lapin BA
Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):109-20. PubMed ID: 8385378
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
